Article Text

PDF
Predictive value of the efficacy of glaucoma medications in animal models: preclinical to regulatory studies
  1. William C Stewart1,
  2. George N Magrath2,
  3. Christina M Demos3,
  4. Lindsay A Nelson3,
  5. Jeanette A Stewart1
  1. 1PRN Pharmaceutical Research Network, LLC, Charleston, South Carolina, USA
  2. 2Medical University of South Carolina, Charleston, South Carolina, USA
  3. 3Charleston Research Company, LLC, Charleston, South Carolina, USA
  1. Correspondence to Dr William C Stewart, 6296 Rivers Avenue, Suite 309, Charleston, SC 29406, USA; info{at}prnorb.com

Abstract

To gain regulatory approval for a new medicine, a pharmaceutical company must take the new product through a series of clinical trials (Phases I–III). Animal models are important in the new drug-development process because they allow for the testing of the efficacy and safety of potential new medicines in a cost-efficient manner that avoids the risk of serious adverse events to humans. Unfortunately, there is no perfect animal treatment model for glaucoma. Animal studies hopefully predict the results of clinical studies, but with estimating efficacy, the limited size and duration of these studies, as well as the animal model selection, might restrict the ability to accurately predict future results. There is little information which compares various available animal models and how well these preclinical studies predict the efficacy of a new product in clinical trials. The purpose of this review article is to analyse animal model studies evaluating potential glaucoma products and determine parameters associated with commercial availability. We discuss how animal models provide some success in predicting commercial launch of a new glaucoma medicine, especially the hypertensive and monkey models, but highlight that caution must be used in interpreting individual models or studies.

  • Animal models
  • glaucoma
  • treatments
  • commercial success
  • commercial failure
  • intraocular pressure
  • treatment medical
  • experimental & animal models

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.